Stand up for the facts!
Our only agenda is to publish the truth so you can be an informed participant in democracy.
We need your help.
I would like to contribute
Social media post takes Pfizer CEO’s COVID-19 ‘rehearsal’ comment out of context
If Your Time is short
-
Pfizer CEO Albert Bourla said in a February 2023 interview that the COVID-19 pandemic was like a rehearsal for how an organization can mobilize to fight against a disease.
-
The broader context of the conversation shows he wasn’t talking about the COVID-19 virus being planned, which is a common conspiracy theory.
-
He also said Pfizer is developing treatments targeting cancer and other diseases.
A Threads post took a year-old statement by Pfizer CEO Albert Bourla out of context to say the executive recently admitted that COVID-19 was used as a test to benefit the pharmaceutical giant.
The June 19 Threads post shared a video clip of Bourla and wrote, "BREAKING: Pfizer CEO Albert Bourla admitted yesterday that Covid was used as a test, while also saying that he believes that the best days of Pfizer are ahead."
The post also shared a truncated quote from Bourla: "I truly think that the best days of Pfizer are ahead of us, because Covid was for me was like a rehearsal." That quote is accurate, but omits the remainder of Bourla’s comment, which is in the video clip shared in the post and a longer video of the event.
This post was flagged as part of Meta’s efforts to combat false news and misinformation on its News Feed. (Read more about our partnership with Meta, which owns Threads, Facebook and Instagram.)
Bourla did not make the comment "yesterday," as the Threads post claimed. He said it Feb. 2, 2023, during a conversation at the Economic Club of Chicago. And Bourla didn’t admit that COVID-19 was a test, as the Threads post said.
Sign up for PolitiFact texts
Bourla responded to a question from Spelman College President Helene Gayle, the conversation moderator, about what it was like at Pfizer’s helm in the pandemic’s wake.
Bourla spoke about Pfizer’s 2022 successes, noting that the company’s medicines reached 1.4 billion people worldwide. Pfizer was the first drug company to have its COVID-19 vaccine approved for emergency use in the U.S. in December 2020 and the first to get full approval from the U.S. Food and Drug Administration in August 2021.
"All of that is great," Bourla said. "But I truly think the best days of Pfizer are ahead of us because COVID was for me like a rehearsal … how you can mobilize an organization and do the impossible possible against a main disease."
Featured Fact-check
"We are after cancer and many other things in the years to come," he added.
Cancer also came up earlier in the conversation. Bourla said partnering with government agencies such as the FDA and doing things differently than usual helped Pfizer develop its COVID-19 vaccine in record time and "changed the course of history."
"If we were able by working together to do that together for COVID, why we don’t do it for cancer?" Bourla said.
The Threads claim mirrors multiple debunked claims since the pandemic began that world leaders or elites planned the virus for control or financial gain. But that’s not what Bourla spoke about at the 2023 event.
We rate the claim that Bourla "admitted yesterday that Covid was used as a test" False.
Our Sources
Threads post, June 19, 2024
The Economic Club of Chicago, Dr. Albert Bourla, chairman and CEO, Pfizer, Feb. 2, 2023
The Economic Club of Chicago, Dr. Albert Bourla, Feb. 2, 2023
U.S. Food and Drug Administration, FDA takes key action in fight against COVID-19 by issuing emergency use authorization for first COVID-19 vaccine, Dec. 11, 2020
U.S. Food and Drug Administration, FDA approves first COVID-19 vaccine, Aug. 23, 2021
Browse the Truth-O-Meter
More by Jeff Cercone
Social media post takes Pfizer CEO’s COVID-19 ‘rehearsal’ comment out of context
Support independent fact-checking.
Become a member!
In a world of wild talk and fake news, help us stand up for the facts.